Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

Market Cap	3.86B
Revenue (ttm)	1.15B
Net Income (ttm)	136.81M
Shares Out	167.44M
EPS (ttm)	0.82
PE Ratio	28.21
Forward PE	25.33
Dividend	0.30 (1.33%)
Ex-Dividend Date	Jun 11, 2025

Volume	9,095,016
Average Volume	5,098,194
Open	22.55
Previous Close	22.50
Day's Range	22.55 - 23.10
52-Week Range	22.00 - 40.19
Beta	0.93
RSI	27.56
Earnings Date	Apr 25, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 600
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688687

Financial Performance

In 2024, SHA:688687's revenue was 1.23 billion, a decrease of -12.87% compared to the previous year's 1.41 billion. Earnings were 142.37 million, an increase of 22.18%.